<DOC>
	<DOCNO>NCT00156273</DOCNO>
	<brief_summary>We try develop good way detect cancer therapy work .</brief_summary>
	<brief_title>Determine Feasibility Quantifying Apoptosis Bcl-2 Expression CTCs Women With Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1.Females least 18 year age 2 Diagnosis metastatic breast cancer 3.ECOG Score 02 4.Treating oncologist decide initiate new systemic therapy emphasis recruit patient commence taxanebased regimen . Taxinebased therapy may docetaxel paclitaxel , give schedule , include weekly every 3 week . Other treatment include nontaxane chemotherapy trastuzumabwith without therapy . 5.Patient willing return one additional ~18 mL blood draw ( ) 2448 , /or 72 hour ~34 week initiation therapy.At minimum , patient must donate blood baseline , one intermediate interval ( 24 , 48 , 72 hr ) ~34 week 6.Signed Informed Consent Form Patient unable unwilling provide blood specimen minimum one intermediate blood draw time point 24 , 48 , 72 hour</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>